NCT06712758 Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients
| NCT ID | NCT06712758 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Visionair Oogzorg |
| Condition | Cataract |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-12 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-11-12 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure. The aim of this data collection is to demonstrate the safety of a new generation of cataract surgical devices in patients who also suffer from glaucoma. They are glaucoma patients who have an increased sensitivity to eye pressure increases both during and after surgery. The new surgical device makes it possible to safely perform cataract surgery under low pressures. This could, at least theoretically, provide an advantage for patients who also suffer from glaucoma.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with glaucoma that are diagnosed with age-related cataract Exclusion Criteria: * Unwilling to sign informed consent * Functionally monophtalmic patient * Endothelial dystrophy * Active uveitis * Known corticosteroid responder * Presence of uncontrolled systemic disease
Contact & Investigator
Koen Willekens
PRINCIPAL INVESTIGATOR
Visionair Oogzorg
Frequently Asked Questions
Who can join the NCT06712758 clinical trial?
This trial is open to participants of all sexes, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06712758 currently recruiting?
Yes, NCT06712758 is actively recruiting participants. Contact the research team at kw@visionairoogzorg.be for enrollment information.
Where is the NCT06712758 trial being conducted?
This trial is being conducted at Geel, Belgium.
Who is sponsoring the NCT06712758 clinical trial?
NCT06712758 is sponsored by Visionair Oogzorg. The principal investigator is Koen Willekens at Visionair Oogzorg. The trial plans to enroll 10 participants.